Antidiabetic drugs

Clifford J. Bailey*, Caroline Day

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Achieving good gtycaemic control is an important part of the treatment strategy to minimise vascular complications in diabetes. An expanding range of differently acting oral antidiabetic agents provides new choices for type 2 patients. This review considers the attributes and limitations of these agents, and their positioning in the treatment process.

Original languageEnglish
Pages (from-to)128-136
Number of pages9
JournalBritish Journal of Cardiology
Issue number2
Publication statusPublished - Mar 2003


  • Acarbose
  • Antidiabetic drugs
  • Insul in
  • Meglitinides
  • Metabolic syndrome
  • Metformin
  • Sulphonylureas
  • Thiazolidinediones
  • Type 2 diabetes


Dive into the research topics of 'Antidiabetic drugs'. Together they form a unique fingerprint.

Cite this